Top Back to top

Evaluation of the EBMT risk score and of a modified EBMT risk score adapted to paediatric patients in paediatric allogeneic transplantation

Study number:
Short title:
Study status:
Deadline for data collection:
Study design:
Primary objective:
To assess EBMT risk score in paediatric allogeneic transplantation. To test a modified EBMT risk score with age classes adapted to paediatrics.
Key inclusion criteria:
all patients
-Aged <18 Yrs at HSCT
-Allogeneic HSCT in an EBMT registered center for an acquired haematological disease
-Date of transplant between 01.01.2000 and 31.12.2012
Principal investigator:
Fanette Bernard
Principal investigator email:
EBMT Study coordinator:
Arnaud Dalissier

Need help?

The personal data provided will be processed according to the General Data Protection Regulation (GDPR 2016/679 ) and incorporated to a file property of EBMT which will be allocated in the EEA (European Economic Area) or in countries that are provided with the same level of protection for privacy such as countries that adhere to EU-US and Swiss-US Privacy Shield Frameworks.
Data Subjects have the right of access to his or her data and the right to rectification of any inaccurate or incomplete personal data. The Data Subject also has the right to withdraw consent, this wish will be respected, and the personal will no longer be made available. If the processing operation is unlawful the Data Subject has the right to request deletion of that data. Please write to